Theravance Biopharma Inc (TBPH)
9.60
-0.13
(-1.34%)
USD |
NASDAQ |
Dec 20, 16:00
9.45
-0.15
(-1.56%)
After-Hours: 20:00
Theravance Biopharma Profit Margin (Quarterly): -75.28% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 25.86% |
| Madrigal Pharmaceuticals Inc | -172.0% |
| Ionis Pharmaceuticals Inc | -105.0% |
| Jazz Pharmaceuticals PLC | 20.38% |
| NovaBay Pharmaceuticals Inc | -49.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.67% |
| Return on Assets | -13.10% |
| Return on Invested Capital | -23.67% |
| Operating Margin (Quarterly) | -54.99% |
| Return on Net Operating Assets | -81.60% |